266 related articles for article (PubMed ID: 29580267)
1. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
[TBL] [Abstract][Full Text] [Related]
2. Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer.
Qureshi S; Elliott RB; Herrington JD
J Oncol Pharm Pract; 2017 Dec; 23(8):625-628. PubMed ID: 27604142
[TBL] [Abstract][Full Text] [Related]
3. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases.
Lecarpentier E; Ouaffi L; Mir O; Berveiller P; Maurel M; Pujade-Lauraine E; Bouillot JL; Veyrie N
Invest New Drugs; 2011 Dec; 29(6):1500-3. PubMed ID: 20676743
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Fournier's Gangrene Caused by Small Intestinal Perforation during Bevacizumab Combination Chemotherapy].
Ishida T; Shinozaki H; Ozawa H; Kobayashi T; Kato S; Wakabayashi T; Matsumoto K; Sasakura Y; Shimizu T; Terauchi T; Kimata M; Furukawa J; Kobayashi K; Ogata Y
Gan To Kagaku Ryoho; 2016 Jul; 43(7):909-11. PubMed ID: 27431640
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
Rodriguez CA; Martin T; Lozano R; Gomez A; Cruz JJ
Breast J; 2017 Nov; 23(6):745-746. PubMed ID: 28845572
[TBL] [Abstract][Full Text] [Related]
8. Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature.
Jayakody S; Wright DB; Chiong C; Liu M; Bouffler C; El-Khoury T
J Med Case Rep; 2018 Aug; 12(1):221. PubMed ID: 30111379
[TBL] [Abstract][Full Text] [Related]
9. [Four Cases of Gastrointestinal Perforation Associated with Bevacizumab].
Uemura K; Takahashi H; Mino K; Ota T; Shichi S
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1604-1606. PubMed ID: 29394716
[TBL] [Abstract][Full Text] [Related]
10. [Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer].
Mychaluk J; Piprot C; Sevestre H; Merviel P; Gondry J; Fauvet R
Presse Med; 2009 Sep; 38(9):1370-4. PubMed ID: 19349140
[No Abstract] [Full Text] [Related]
11. [A Case of Axillary Arterial Bleeding after Axillary Metastatic Lymph Node Necrosis during Treatment with Paclitaxel and Bevacizumabfor Breast Cancer].
Abe N; Ohtake T; Abe S; Aoto K; Okano M; Tachibana K; Yoshida S; Yasuda M; Kimijima I; Takenoshita S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2062-2064. PubMed ID: 28133222
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer.
Tamiya M; Suzuki H; Shiroyama T; Tanaka A; Morishita N; Okamoto N; Sakai K; Shigeoka H; Kawahara K; Hirashima T
Invest New Drugs; 2018 Aug; 36(4):696-701. PubMed ID: 29536229
[TBL] [Abstract][Full Text] [Related]
13. Rare Case of Endoscopic Treatment for Bevacizumab-Related Gastric Perforation in a Patient with Ovarian Cancer.
Cappuccio S; Marinucci B; Bove V; Turco LC; Cosentino F; Scambia G; Costamagna G; Boškoski I
Chemotherapy; 2020; 65(1-2):54-57. PubMed ID: 32615577
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Multiple Bevacizumab-Related Colonic Perforations during Opioid Use].
Kurata T; Makita N; Hagino S; Iwata K; Tsuneda A; Kiriyama M
Gan To Kagaku Ryoho; 2016 Jan; 43(1):95-7. PubMed ID: 26809533
[TBL] [Abstract][Full Text] [Related]
15. Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report.
Yanagihara K; Takei H; Iida S; Yamashita K; Kurita T; Iwamoto M; Saegusa H; Uchida E
J Nippon Med Sch; 2014; 81(5):333-6. PubMed ID: 25391703
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Biweekly Paclitaxel and Bevacizumab].
Yoshida T; Goto Y; Sakiyama K; Kimura M
Gan To Kagaku Ryoho; 2016 Nov; 43(11):1397-1400. PubMed ID: 27899783
[TBL] [Abstract][Full Text] [Related]
17. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
Abbrederis K; Kremer M; Schuhmacher C
Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
[TBL] [Abstract][Full Text] [Related]
18. [Four cases of bevacizumab-related gastrointestinal perforation].
Uchino T; Mishima H; Kimura K; Mori D; Ando K; Nagata H; Kondo R; Kosaka K; Ohashi N; Ito N; Arikawa T; Miyachi M; Suzumura K; Sano T; Nonami T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2506-8. PubMed ID: 25731572
[TBL] [Abstract][Full Text] [Related]
19. [Nasal septum perforation and bevacizumab].
Bengrine-Lefevre L; Afchain P; Chibaudel B; Gervais H; Tournigand C; De Gramont A; Louvet C
Rev Med Interne; 2011 Apr; 32(4):e43-5. PubMed ID: 21470582
[TBL] [Abstract][Full Text] [Related]
20. Recurrent Cervical Cancer with Intestinal Perforation That Was Related to Bevacizumab after Long-term NSAIDs Administration and Was Treated with Laparoscopy-assisted Anastomosis.
Iida T; Muramatsu T; Nakajima R; Narayama C; Narayama T; Goya K; Tsukada H; Maeda H; Machida T; Kuramoto T; Mikami M
Tokai J Exp Clin Med; 2019 Sep; 44(3):40-44. PubMed ID: 31448394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
